Editas Medicine, Inc. Common Stock

  • EDIT

  • $3.38

  • +2.42%

  • $3.30

  • $0.0000

  • $0.0000

Prices as of 2026-04-22 09:31:09 ET

Ticker Appearances

Signal From Noise
Sat, April 5, 2025 | 10:30AM ET
Group135
Fundstrat Direct Team

CRISPR ― Improving Our Original Recipes

In 2020, Drs. Jennifer Doudna and Emmanuelle Charpentier won the Nobel Prize in Chemistry for developing the gene-editing tool known as CRISPR. In the words...

Events

Tickers

Trending tickers in our research